{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:52:26Z","timestamp":1780437146635,"version":"3.54.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T00:00:00Z","timestamp":1250726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00277-009-0810-y","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T13:02:44Z","timestamp":1250686964000},"page":"421-422","source":"Crossref","is-referenced-by-count":5,"title":["Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report"],"prefix":"10.1007","volume":"89","author":[{"given":"Wan Kyu","family":"Eo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Ha","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Soo","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Kyung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Suck","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung Yeol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,20]]},"reference":[{"key":"810_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","volume":"56","author":"FA Pereira","year":"2007","unstructured":"Pereira FA, Mudgil AV, Rosmarin DM (2007) Toxic epidermal necrolysis. J Am Acad Dermatol 56:181\u2013200. doi: 10.1016\/j.jaad.2006.04.048","journal-title":"J Am Acad Dermatol"},{"key":"810_CR2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archderm.1987.01660330067010","volume":"123","author":"J Revuz","year":"1987","unstructured":"Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R (1987) Treatment of toxic epidermal necrolysis. Cr\u00e9teil's experience. Arch Dermatol 123:1156\u20131158. doi: 10.1001\/archderm.123.9.1156","journal-title":"Arch Dermatol"},{"key":"810_CR3","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1592\/phco.19.15.1177.30571","volume":"19","author":"SB Horowitz","year":"1999","unstructured":"Horowitz SB, Stirling AL (1999) Thalidomide-induced toxic epidermal necrolysis. Pharmacotherapy 19:1177\u20131180. doi: 10.1592\/phco.19.15.1177.30571","journal-title":"Pharmacotherapy"},{"key":"810_CR4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJM200009283431315","volume":"343","author":"SV Rajkumar","year":"2000","unstructured":"Rajkumar SV, Gertz MA, Witzig TE (2000) Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma. N Engl J Med 343:972\u2013973. doi: 10.1056\/NEJM200009283431315","journal-title":"N Engl J Med"},{"key":"810_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115:149\u2013153. doi: 10.1046\/j.1523-1747.2000.00061.x","journal-title":"J Invest Dermatol"},{"key":"810_CR6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mjd.2003.87","volume":"48","author":"VC Hall","year":"2003","unstructured":"Hall VC, El-Azhary RA, Bouwhuis S, Rajkumar SV (2003) Dermatologic side effects of thalidomide in patients with multiple myeloma. J Am Acad Dermatol 48:548\u2013552. doi: 10.1067\/mjd.2003.87","journal-title":"J Am Acad Dermatol"},{"key":"810_CR7","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2002.02.116","volume":"20","author":"SV Rajkumar","year":"2002","unstructured":"Rajkumar SV, Hayman S, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR, Geyer S, Iturria N, Fonseca R, Lust JA, Kyle RA, Witzig TE (2002) Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. J Clin Oncol 20:4319\u20134323. doi: 10.1200\/JCO.2002.02.116","journal-title":"J Clin Oncol"},{"key":"810_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","volume":"139","author":"C Prins","year":"2003","unstructured":"Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K, Trent J, Margolis DJ, Saurat JH, French LE, TEN-IVIG Study Group (2003) Toxic epidermal necrolysis-intravenous immunoglobulin. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 139:26\u201332. doi: 10.1001\/archderm.139.1.26","journal-title":"Arch Dermatol"},{"key":"810_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.139.1.39","volume":"139","author":"JT Trent","year":"2003","unstructured":"Trent JT, Kirsner RS, Romanelli P, Kerdel FA (2003) Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Arch Dermatol 139:39\u201343. doi: 10.1001\/archderm.139.1.39","journal-title":"Arch Dermatol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0810-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-009-0810-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0810-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T14:55:29Z","timestamp":1590072929000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-009-0810-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,20]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1007\/s00277-009-0810-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,20]]}}}